Sunday, June 4, 2023 | Back issues
Courthouse News Service Courthouse News Service

Securities Class

SAN FRANCISCO - Shareholders must amend claims that Amyris Inc. and its CEO John Melo knowingly misrepresented production levels of the chemical product Biofene.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.